Beranda › Penyakit Paru Interstisial › Utah › Salt Lake City
Uji klinis Penyakit Paru Interstisial di Salt Lake City, UT
9 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi sekitar Salt Lake City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Menerima pesertaFase 3
- University of Utah Health Sciences Center, Salt Lake City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaFase 3
- USA025, Salt Lake City
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Menerima pesertaFase 3
- GSK Investigational Site, Salt Lake City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Menerima pesertaFase 2
- University of Utah, Salt Lake City
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Menerima peserta
- University of Utah, Salt Lake City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Menerima pesertaStudi observasional
- University of Utah Health, Salt Lake City
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Menerima pesertaStudi observasional
- University of Utah, Salt Lake City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Menerima pesertaFase 3
- University of Utah Health, Salt Lake City
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Menerima pesertaFase 2
- aTyr Investigative Site, Salt Lake City
Uji klinis Penyakit Paru Interstisial di kota lain
- New York City, NY18 studi
- Philadelphia, PA16 studi
- Los Angeles, CA14 studi
- Charleston, SC13 studi
- Kansas City, KS13 studi
- Durham, NC13 studi
- Chicago, IL12 studi
- Houston, TX12 studi
- Aurora, CO11 studi
- Ann Arbor, MI11 studi
- Dallas, TX9 studi
- Boston, MA9 studi
Studi lain di Salt Lake City
- Kanker Paru Non-Sel Kecil31 studi
- Kanker (semua jenis)27 studi
- Kanker Payudara27 studi
- Kanker Kolorektal22 studi
- Kanker Paru21 studi
- Melanoma21 studi
- Mieloma Multipel21 studi
- Kanker Metastatik20 studi
- Kanker Ovarium19 studi
- Obesitas18 studi
- Leukemia Mieloid Akut17 studi
- Gagal Jantung17 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.